Status:
COMPLETED
Normotonic Partial Nephrectomy as Novel Approach in Treating Small Renal Masses
Lead Sponsor:
Saint Petersburg State University, Russia
Conditions:
Renal Malignant Tumor
Renal Tumor
Eligibility:
All Genders
18-85 years
Phase:
NA
Brief Summary
This study evaluates novel surgical approach in treating small renal masses. Half of participants will undergo hypotonic zero-ischaemia partial nephrectomy (standard of care), while the other half wil...
Detailed Description
Partial nephrectomy is believed to be the gold standard for treating small renal masses (SRM). The warm ischaemia and hypotonic zero-ischaemia approach are widely used techniques of care. But they hav...
Eligibility Criteria
Inclusion
- Suspected by computed tomography or another instrumental method renal mass
- Clinical stage T1-2N0-2M0-1 (distant metastases must be resectable)
- Indications for partial nephrectomy
- Eastern Cooperative Oncology Group status 0-2
- At least 18 years of age
- Written informed consent
Exclusion
- Medical or psychiatric conditions that compromise the patient's ability to give informed consent or comply with the study protocol
- Pregnancy or breast feeding
- Medical contraindications for surgical treatment
- Synchronous or metachronous malignancy
- Non-resectable distant metastases
- The patient's refusal to perform research procedures.
- Refusal of the patient to continue participation in the study.
Key Trial Info
Start Date :
October 7 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 7 2022
Estimated Enrollment :
108 Patients enrolled
Trial Details
Trial ID
NCT04096534
Start Date
October 7 2019
End Date
May 7 2022
Last Update
May 25 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
State University Clinic
Saint Petersburg, Russia